Outset Medical, Inc.'s SEC filings document operating results, product and service revenue, gross margin, cash resources, and guidance for its dialysis technology business. Recent Form 8-K reports furnish earnings releases for the Tablo Hemodialysis System business and disclose material events such as FDA 510(k) clearance for the next-generation Tablo platform.
Proxy materials and current reports also cover governance and compensation matters, including board composition, director independence, committee appointments, executive compensation tables, pay-versus-performance disclosures, and equity awards. The filing record ties these disclosures to Outset’s capital structure, Nasdaq-listed common stock, and medical-device regulatory environment.
Outset Medical, Inc. ownership disclosure: BML Investment Partners, L.P. reports beneficial ownership of 2,519,706 shares of common stock, representing 13.6% of the class. The filing states shared voting and dispositive power of 2,519,701 shares and names Braden M. Leonard as indirect owner via BML Capital Management, LLC.
Outset Medical, Inc. disclosed that investment entity BML Investment Partners, L.P., associated with major holder Leonard Braden Michael, acquired 323,000 shares of common stock at $5.00 per share. The shares were assigned upon expiration of short June 2026 put options held by the reporting owner.
Following this option assignment, BML Investment Partners, L.P. indirectly holds 2,519,701 shares of Outset Medical common stock. Mr. Leonard, as managing member of BML Capital Management, LLC, exercises voting and investment control over the fund’s holdings but disclaims beneficial ownership except to the extent of his pecuniary interest.
OM reported a Section 144 notice describing restricted stock units that vested and were settled into 5,033 shares on 05/15/2026. The filing also shows a prior sale of 2,862 shares on 02/17/2026 attributed to John Brottem. The transaction is listed as equity compensation for services rendered.
OM reported a Form 144 disclosure showing a settlement of 4,277 vested Restricted Stock Units into Common Stock on 05/15/2026. The filing also records 1,830 shares of Common Stock sold on 02/17/2026 by Marc Nash within the prior three months.
OM submitted a Form 144 notice reporting 9,319 shares of Common Stock tied to the settlement of vested restricted stock units scheduled on 05/15/2026. The filing also records a prior sale of 3,384 shares on 02/17/2026 by Leslie Trigg. The transaction is described as equity compensation for services rendered.
Outset Medical, Inc. amendment to a Schedule 13G/A reports that Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh beneficially own 0 shares of Common Stock, representing 0.00% of the class as of 03/31/2026.
The filing is a joint statement under Rule 13d-1(k) signed by each party and certified by Jason Bragg, Chief Financial Officer, and Anand Parekh on 05/15/2026.
Outset Medical, Inc. disclosure amendment: Woodline Partners reports beneficial ownership of 292,437 shares of Outset Medical common stock, representing 1.6% based on 18,311,626 shares outstanding as of February 10, 2026. The shares are held directly by Woodline Master Fund LP and Woodline reports sole voting and dispositive power over 292,437 shares.
The filing is an amendment to a prior Schedule 13G and cites the Company’s Annual Report for the outstanding share count as of February 10, 2026.
Outset Medical, Inc. filing an amendment to a Schedule 13G that updates beneficial ownership for BML Investment Partners, L.P. The filing reports 2,196,701 shares of Common Stock and a 11.8% ownership stake, with shared voting and dispositive power reported.
The filing states that BML Investment Partners, L.P. is a Delaware limited partnership; BML Capital Management, LLC is its sole general partner and Braden M. Leonard is the managing member, who is deemed an indirect owner of the reported shares. The signature is dated 05/12/2026.
Outset Medical, Inc. insider activity shows entities associated with Michael Leonard exercising in-the-money derivatives to acquire additional common stock. BML Investment Partners, L.P. acquired 197,600 and 96,900 shares of common stock at $5.00 per share, bringing its indirectly held position to 2,196,701 shares. These holdings are managed by BML Capital Management, LLC, where Leonard is the managing member with investment and voting control, while he disclaims beneficial ownership beyond his pecuniary interest. The filing also notes outstanding indirect positions in short put options over additional common shares.